Norges Bank’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-145,582
| Closed | -$14.8M | – | 2054 |
|
|
2023
Q2 | $14.8M | Sell |
145,582
-19,900
| -12% | -$2.03M | ﹤0.01% | 1389 |
|
|
2023
Q1 | $15M | Sell |
165,482
-39,837
| -19% | -$3.62M | ﹤0.01% | 1409 |
|
|
2022
Q4 | $7.8M | Buy |
205,319
+6,589
| +3% | +$250K | ﹤0.01% | 1639 |
|
|
2022
Q3 | $4.99M | Hold |
198,730
| – | – | ﹤0.01% | 1766 |
|
|
2022
Q2 | $6.04M | Buy |
198,730
+10,848
| +6% | +$330K | ﹤0.01% | 1725 |
|
|
2022
Q1 | $6.16M | Sell |
187,882
-30,843
| -14% | -$1.01M | ﹤0.01% | 1829 |
|
|
2021
Q4 | $5.77M | Hold |
218,725
| – | – | ﹤0.01% | 1894 |
|
|
2021
Q3 | $22M | Buy |
218,725
+5,228
| +2% | +$526K | ﹤0.01% | 1428 |
|
|
2021
Q2 | $30.2M | Buy |
213,497
+19,759
| +10% | +$2.8M | 0.01% | 1274 |
|
|
2021
Q1 | $19.3M | Sell |
193,738
-7,036
| -4% | -$702K | ﹤0.01% | 1564 |
|
|
2020
Q4 | $24.8M | Sell |
200,774
-9,279
| -4% | -$1.15M | 0.01% | 1432 |
|
|
2020
Q3 | $20.5M | Sell |
210,053
-27,859
| -12% | -$2.71M | 0.01% | 1407 |
|
|
2020
Q2 | $37.1M | Sell |
237,912
-11,564
| -5% | -$1.8M | 0.01% | 1044 |
|
|
2020
Q1 | $36M | Sell |
249,476
-5,839
| -2% | -$843K | 0.01% | 866 |
|
|
2019
Q4 | $52.2M | Buy |
255,315
+136,398
| +115% | +$27.9M | 0.01% | 883 |
|
|
2019
Q3 | $9.55M | Buy |
+118,917
| New | +$9.55M | ﹤0.01% | 1792 |
|